Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
Patents for C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
01/2014
01/08/2014EP2681212A1 Crystalline compound comprising tiotropium bromide
01/08/2014EP2681211A1 Crystalline compound comprising tiotropium bromide
01/08/2014CN103497177A Amino heterocyclic aromatic compound serving as c-Met inhibitor, and preparation method thereof
12/2013
12/25/2013EP2676956A1 Tetrahydropyridinyl and dihydropyrrolyl compounds and the use thereof
12/24/2013US8614330 Substituted benz-azoles and methods of their use as inhibitors of RAF kinase
12/18/2013CN103450182A Preparation and purification methods of Retapamulin
12/17/2013US8609690 Aryl- and heteroarylcarbonyl derivatives of substituted nortropanes, medicaments containing such compounds and their use
12/17/2013US8609685 SMAC mimetic compounds as apoptosis inducers
12/17/2013CA2697051C Substituted-quinoxaline-type piperidine compounds and the uses thereof
12/12/2013US20130331349 Compositions and methods for modulating fxr
12/11/2013EP2670746A1 Bicyclic heteroaryl compounds as gpr119 receptor agonists
12/11/2013CN103443099A Compositions and methods for modulating FXR
12/11/2013CN101993442B Novel crystal forms of benzilic acid nortropinyl hydrochloride and preparation method thereof
12/10/2013US8604195 Substituted bicyclic piperidinyl- and piperazinyl-sulfonamides useful to inhibit 11β-hydroxysteroid dehydrogenase type-1
12/05/2013US20130324572 Remedy for psychoneurotic diseases
12/05/2013US20130324517 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
11/2013
11/28/2013US20130317000 N-substituted benzamides and methods of use thereof
11/27/2013CN103408543B High purity citric acid and navoban compound
11/27/2013CN103408543A High purity citric acid and navoban compound
11/26/2013US8592395 Therapeutic compounds
11/21/2013US20130310379 Modulators of methyl modifying enzymes, compositions and uses thereof
11/21/2013US20130310366 5-ht3 receptor modulators, methods of making, and use thereof
11/21/2013US20130310357 Azolyl Urea Compounds and Methods of Use Thereof
11/19/2013US8586585 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease
11/14/2013US20130303570 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
11/12/2013CA2675419C Heterocyclic-substituted piperidine compounds and the uses thereof
11/07/2013US20130295049 Linked dibenzimidazole antivirals
11/05/2013US8575192 Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
11/05/2013US8574545 Labeled iodinated tropane formulation
10/2013
10/30/2013EP2655370A1 Compositions and methods for modulating fxr
10/29/2013US8568699 Soft anticholinergic zwitterions
10/24/2013US20130281485 Bridged bicyclic rho kinase inhibitor compounds, compositions and use
10/24/2013US20130281476 Modulators of Muscarinic Receptors
10/24/2013US20130281428 Pyridone Derivatives
10/24/2013US20130281359 New bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors
10/23/2013EP2651913A1 Indeno- fused ring compounds having photochromic properties
10/23/2013CN103360386A Tropisetron hydrochloride compound, its preparation method, and pharmaceutical composition containing the same
10/17/2013US20130274265 Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
10/16/2013EP2650290A1 Cyclic amine compound and pest control agent
10/15/2013US8557842 Cocaine analogs and methods of preparation and uses thereof
10/03/2013WO2013149136A1 ISOXAZOLE β-LACTAMASE INHIBITORS
10/03/2013WO2013143510A1 A method of preparing the scopine ester of di-(2-thienyl)glycolic acid, an intermediate in the synthesis of tiotropium bromide
10/03/2013US20130261129 Chemokine receptor antagonists
10/02/2013EP2643295A1 Glycine derivatives and their use as muscarinic receptor antagonists
10/02/2013CN103339123A Indeno- fused ring compounds having photochromic properties
09/2013
09/25/2013CN103319478A Synthesis process of important medicinal chemical raw material bromomethyl scopolamine
09/19/2013WO2013135219A1 A method of preparing the scopine ester of di-(2-thienyl)glycolic acid, an intermediate in the synthesis of tiotropium bromide, and its new form
09/19/2013WO2013107434A3 Amorphous and solvated polymorphous forms of tiotropium iodide and a method their preparation
09/19/2013US20130245128 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
09/11/2013CN103298473A Therapeutic compositions for diabetic symmetrical polyneuropathy
09/11/2013CN103288694A Preparation method of pleuromutilin synthetic derivate salt crystal
09/10/2013CA2627982C Soft anticholinergic esters
09/04/2013EP2632468A1 Therapeutic compositions for diabetic symmetrical polyneuropathy
08/2013
08/28/2013CN1538951B Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of chemotaxis of polymorphonucleate and mononucleate cells
08/27/2013CA2611902C Tiotropium salts, compositions thereof, and processes for preparing same via tiotropium bicarbonate reacted with an acid
08/15/2013WO2013117886A1 Process for preparing tiotropium bromide
08/15/2013US20130211091 Crystalline forms of maraviroc phosphate and process for maraviroc amorphous form
08/14/2013CN102227424B Modulators of cystic fibrosis transmembrane conductance regulator
08/08/2013US20130203987 Ampk-activating heterocyclic compounds and methods for using the same
08/01/2013WO2013112622A1 (1r,4r) 7-oxo-2-azabicyclo[2.2.2]oct-5-ene and derivatives thereof
08/01/2013US20130197217 1, 2, 4-triazolone derivative
08/01/2013US20130197027 Heterocyclyl-azabicyclo[3.2.1]octane analogs as selective m1 agonists and methods of making and using same
08/01/2013US20130196952 Heterocyclic derivatives for the treatment of diseases
08/01/2013CA2857969A1 (1r,4r) 7-oxo-2-azabicyclo[2.2.2]oct-5-ene and derivatives thereof
07/2013
07/30/2013CA2561305C Tetrahydro-indazole cannabinoid modulators
07/25/2013WO2013107434A2 New polymorphous forms of tiotropium iodide and a method of their preparation
07/25/2013US20130190351 Bicyclic amides for enhancing glutamatergic synaptic responses
07/24/2013EP2616465A1 Triazine-oxadiazoles
07/24/2013CN103221408A Triazine-oxadiazoles
07/24/2013CN103221390A Glycine derivatives and their use as muscarinic receptor antagonists
07/18/2013US20130184261 Pyridazinone derivatives
07/18/2013US20130184260 Pyridazinone derivatives
07/17/2013CN101528225B 2-aminobenzoxazole carboxamides as 5HT3 modulators
07/16/2013CA2544352C Crystalline anhydrate with anticholinergic effect
07/10/2013EP2611446A1 Crystalline forms of maraviroc phosphate and process for maraviroc amorphous form
07/09/2013US8481518 Quaternary antimuscarinic compounds for the treatment of bladder diseases
07/04/2013US20130172379 Combined Acetylcholinesterase Inhibitor and Quaternary Ammonium Antimuscarinic Therapy to Alter Progression of Cognitive Diseases
07/03/2013EP2609096A1 New tiotropium bromide crystal and its production method
07/02/2013US8476440 Process for preparing an intermediate to mu opioid receptor antagonists
07/02/2013US8476296 Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]OCT-3-yl)-3,5-difluorobenzamide
06/2013
06/27/2013WO2013064919A9 Quinazoline derivatives with hsp90 inhibitory activity
06/27/2013US20130165656 Continuous process for the alkylation of cyclic tertiary amines
06/26/2013CN103172481A Continuous process for the alkylation of cyclic tertiary amines
06/26/2013CN102180878B Dolasetron isomer or salt thereof, preparation method for the Dolasetron isomer or salt thereof and application of the Dolasetron isomer or salt thereof
06/25/2013US8470846 Remedy for psychoneurotic diseases
06/25/2013US8470786 Pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same
06/22/2013CA2793619A1 Continuous process for the alkylation of cyclic tertiary amines
06/20/2013WO2013090260A1 Nicotinic receptor targeted compounds and compositions
06/20/2013US20130158060 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
06/20/2013US20130157981 Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
06/19/2013CN103159754A Amino propyl replacing tropane amine compound, medical composition thereof, preparation method and purpose thereof
06/18/2013CA2561558C Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
06/13/2013US20130150377 Tetrahydropyridinyl and Dihydropyrrolyl Compounds and the Use Thereof
06/12/2013EP2601185A1 Derivatives of pyrazolophenyl-benzenesulfonamide compounds and use thereof as antitumor agents
06/12/2013CN103153980A Derivatives of pyrazolophenyl-benzenesulfonamide compounds and use thereof as antitumor agents
06/12/2013CN102351857B Tropiseiron hydrochloride compound
06/12/2013CN101684117B Method for preparing nor-tropine
06/11/2013CA2725704C Industrial process for preparing tropenol
06/06/2013WO2013079040A1 Mixed solvate of tiotropium bromide and a method of its preparation
06/05/2013CN103130798A Novel crystal of tiotropium bromide
1 2 3 4 5 6 7 8 9 10 11 12 13 ... 53